FDA Brief

FDA warning letters

A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.

423 letters match. Newest first.

  1. Sovereign Pharmaceuticals, LLC

    FDA cited Sovereign Pharmaceuticals for manufacturing failures in bulk tablets, inadequate out-of-specification (OOS) investigations, quality-unit lapses, and an unapproved biological product.

    High risk
  2. Lakpura LLC

    FDA and Federal Trade Commission warned Lakpura LLC over ayurvedic products and teas with unapproved COVID-19 claims.

    High risk
  3. South Pork Ranch Equipment LLC

    South Pork Ranch Equipment marketed unapproved Cydectin and Blackstrap animal drugs for treating disease in goats, sheep, and cattle online.

    High risk
  4. Flawless Beauty and Skin

    FDA says Flawless Beauty and Skin marketed unapproved microneedling devices and failed to register as an initial importer.

    Medium
  5. Bespoke Apothecary LLC

    Bespoke Apothecary sold COVID kit and herbal tea with unapproved COVID-19 treatment claims, FDA and FTC say.

    Low
  6. Muscle Sports Products, LLC

    Muscle Sports Products sold supplements as unapproved new drugs with disease claims, including COVID-19, FDA says.

    High risk
  7. The Elderberry Fairy & Co., LLC

    FDA warns The Elderberry Fairy & Co. that elderberry syrups and Organic Fire Cider are unapproved new drugs and misbranded.

    Low
  8. USA Medical LLC

    FDA: USA Medical sold unapproved COVID-19 antigen tests with false EUA claims and lacked basic quality system procedures.

    High risk
  9. Ariella Naturals

    FDA warned Ariella Naturals that its website sells unapproved mole and skin tag removal drugs without FDA approval.

    High risk
  10. Amazon.com, Inc.

    Amazon distributes unapproved new drugs for mole and skin tag removal, FDA says.

    High risk
  11. Vitti Labs, LLC

    FDA warns Vitti Labs over unapproved umbilical cord and amniotic membrane products and sterile manufacturing failures.

    High risk
  12. FluxxLab LLC

    FDA and FTC warned FluxxLab that its COVID-19 and CBDA/CBD tinctures are unapproved, misbranded drugs marketed with unsupported COVID-19 claims.

    High risk
  13. Custom Research Labs Inc.

    FDA warned Custom Research Labs Inc. about manufacturing-practice violations and unapproved, misbranded OTC drugs, including hand sanitizers and topical analgesics.

    High risk
  14. Living Foods LLC

    FDA warned Living Foods LLC that its Bion+Plus, ZeoHeal and Relax Sauna were marketed with unapproved drug and device claims.

    High risk
  15. H2 Beverages, Inc.

    H2 Beverages' hydrogen-infused water beverages are unapproved new drugs and misbranded because of disease and COVID-19 claims.

    High risk
  16. Elite Supplement Center LLC and Elite Training Facility LLC

    FDA warned Elite Supplement Center that it sells five SARM products as unapproved new drugs for human use.

    High risk
  17. Thirsty Run LLC / US Royal Honey LLC

    FDA found hidden Viagra and Cialis ingredients in three royal honey products sold online as supplements and drugs.

    High risk
  18. DDI Multinacional S.A. de C.V.

    DDI Multinacional hand sanitizers labeled 70% ethanol contained up to 60% methanol, leading to adulteration and import alert.

    High risk
  19. Herbsens Botanicals

    Herbsens Botanicals marketed kratom capsules and powders as unapproved drugs to treat opioid addiction and other conditions.

    High risk
  20. Kratom Exchange

    FDA and FTC warned Kratom Exchange that it sells kratom as unapproved new drugs for opioid addiction and other conditions.

    High risk
  21. Omni Consumer Products LLC d/b/a YoKratom

    FDA and FTC warned YoKratom that its kratom products are unapproved new drugs marketed to treat opioid addiction.

    High risk
  22. MONQ, LLC

    MONQ sold unapproved inhalation essential oil products with claims to treat opioid addiction and withdrawal, FDA and FTC said.

    High risk
  23. Industrias Cklass S. de R.L. de C.V.

    FDA found Industrias Cklass hand sanitizer labeled 70% ethanol contained 19% ethanol and 48% methanol and was refused U.S. admission.

    High risk
  24. Golden Lab LLC

    Golden Lab sold eye and allergy capsules with unapproved drug claims and lacked required supplement manufacturing controls.

    High risk
  25. Equine Podiatry Solutions, LLC

    Equine Podiatry Solutions marketed Desmosphyrine, an unapproved new animal drug, for treating laminitis in horses.

    High risk
  26. Haniel Concepts, Inc. DBA Free State Oils, LLC

    FDA warned Free State Oils over website claims that its CBD products treat disease, including COVID-19, and are unapproved drugs and adulterated foods.

    High risk
  27. Ayuryoga, Inc.

    FDA warned Ayuryoga/Kottakkal Ayurveda USA that its ayurvedic products are unapproved new drugs promoted with disease-treatment claims online.

    High risk
  28. Santhigram Kerala Ayurvedic Co. of U.S., Inc.

    FDA told Santhigram Kerala Ayurvedic Co. of U.S. that its ayurvedic products are unapproved new drugs sold with disease claims online.

    High risk
  29. Inhousepharmacy.vu

    Vanuatu online pharmacy Inhousepharmacy.vu sold unapproved domperidone to US consumers over the internet.

    High risk
  30. Delta 8 Hemp

    FDA warned Delta 8 Hemp over unapproved Delta-8 THC drugs and adulterated gummies sold online.

    High risk
  31. ATLRx, Inc.

    FDA warned ATLRx that its CBD and Delta-8 THC products are unapproved drugs with illegal disease claims.

    High risk
  32. MYA International, Inc.

    FDA warned MYA International that its supplement and herbal product labels made unapproved drug claims and its dietary supplements violated manufacturing quality and labeling rules.

    High risk
  33. Rena's Organic

    U.S. Food and Drug Administration (FDA) warned Rena's Organic over unapproved CBD drug claims for tinctures, creams, foods, and pet product.

    High risk
  34. Guangzhou Zhongkebaishi Health Industry Co., Ltd.

    Guangzhou Zhongkebaishi's Hand Sanitizer Gel, labeled 75% ethanol, tested at 51% and was refused US import.

    High risk
  35. Kleenhanz, LLC

    FDA told Kleenhanz its antiseptic towelettes were unapproved drugs because the website and Twitter claimed they fight COVID-19 and other diseases.

    High risk
  36. Elements Brands Inc.

    FDA warned Elements Brands that its eb5 Skin Lightening Cream is an unapproved, misbranded new drug.

    High risk
  37. SkinPro

    SkinPro sells an unapproved, misbranded hydroquinone skin-bleaching drug without FDA approval.

    High risk
  38. Neoteric Cosmetics, Incorporated/Scott’s Liquid Gold, Inc.

    FDA warned Neoteric Cosmetics and parent Scott's Liquid Gold that ALPHA Skin Care Dual Action Fade Cream, a hydroquinone skin lightener, is an unapproved and misbranded drug.

    Medium
  39. Skin Authority, L.L.C.

    FDA warns Skin Authority that its skinauthority Hyperpigmentation Treatment is an unapproved and misbranded skin-bleaching drug.

    High risk
  40. Genomma Lab USA, Inc.

    Genomma Lab USA sold two hydroquinone skin-lightening creams as unapproved and misbranded new drugs, FDA says.

    High risk
  41. True Earth Health Products, LLC

    FDA warned True Earth Health Products over Plexaderm Dark Spot Fade Gel, an unapproved, misbranded hydroquinone skin-bleaching drug.

    High risk
  42. www.wellerectile.com

    FDA warned India-based www.wellerectile.com over selling unapproved, improperly labeled drugs online, including hydroxychloroquine claimed to treat COVID-19.

    High risk
  43. CofixRx, LLC

    FDA warned CofixRx that its CofixRX Nasal Spray is an unapproved, misbranded drug sold with COVID-19 prevention claims.

    High risk
  44. NDAL Mfg Inc.

    NDAL Mfg's honey nasal sprays had manufacturing-rule violations, microbial contamination, and lacked FDA approval as new drugs.

    High risk
  45. Honey Feast, Inc.

    Honey Feast, Inc. sold honey products online with disease-treatment claims, making them unapproved new drugs and misbranded.

    Low
  46. Functional Remedies, LLC D/B/A Synchronicity Hemp Oil

    FDA and FTC told a Louisville, Colorado hemp and CBD seller that its website claims the products treat or prevent COVID-19, making them unapproved and misbranded drugs.

    High risk
  47. Greenway Herbal Products LLC

    FDA and FTC warned GreenWay Herbal Products that CBD website claims to prevent and treat COVID-19 make its products unapproved, misbranded drugs.

    High risk
  48. Cureganics

    Cureganics sold CBD products with website claims they prevent or treat COVID-19, making them unapproved and misbranded drugs.

    High risk
  49. Nature's Highway

    FDA and FTC warned CBD seller Nature's Highway for selling unapproved drugs claimed to treat or prevent COVID-19.

    High risk
  50. UPSY LLC

    FDA and FTC warned UPSY LLC that its website sells CBD products claimed to treat or prevent COVID-19 as unapproved, misbranded drugs.

    High risk